Ecorobotix has completed a fundraising
May 2023 — Ecorobotix has raised US$52 million. The new capital will enable the company to grow into new markets, expand its product range and build on the existing commercial success of ARA in Europe.
Ecorobotix, the Swiss manufacturer of ARA, develops, produces and sells innovative farming machines that require low energy and reduce the negative ecological impact of modern agriculture, while keeping costs competitive.
Our role in the transaction
Oaklins’ team in France acted as fundraising advisor in the operation.
Talk to the deal team
Related deals
360 Experience Group has merged with GoodFellows
360 Experience Group, a European end-to-end service provider of live experiences, and GoodFellows have merged to create one of the largest live experiences players in Europe. By pooling their strengths under the 360 Experience Group banner, the merged group will span the full breadth of the live industry and bring together 16 specialized companies, including Live Legends, Unlimited Productions, Unbranded, TIG Sports and Events and Kumpany. The group will provide end-to-end solutions for the realization of large-scale live entertainment, international sports and public events and impactful brand activations. The combined business will generate over US$90 million in revenue and employ more than 230 people.
Learn moreF.EE has been acquired by One Equity Partners
F.EE GmbH, one of Germany’s leading providers of innovative solutions in mechanical engineering, automation hardware, cabinet control, software and robot programming, has been acquired by One Equity Partners. This transaction will strengthen the private equity firm’s operations in the industrial automation space. The sellers have reinvested and will remain involved in the business for the coming years.
Learn moreBharal Développement (Difagri) has acquired Dietagro
Bharal Développement Group, comprising the Difagri and Alinova brands, has acquired Dietagro as part of its build-up strategy to expand its industrial capabilities and further diversify its expertise across animal species and dosage forms.
Learn more